Selective Increase of Vβ2+ T Cells in the Small Intestinal Mucosa in Kawasaki Disease
- 1 February 1996
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 39 (2) , 264-266
- https://doi.org/10.1203/00006450-199602000-00013
Abstract
The current study tested the hypothesis that the gastrointestinal tract could be one of the primary sites of entry for etiologic agents in Kawasaki disease (KD). In an attempt to elucidate the pathogenic role of certain superantigenic agents in KD, T cell receptor Vβ expression by T cells in the small intestinal mucosa of KD patients was investigated using MAb on frozen tissue sections. Twelve Japanese patients with KD and eight controls were enrolled in the study. The numbers of cells stained by an immunofluorescence from each study group were counted and analyzed statistically by the t test. The occurrence of Vβ2+ T cells was found to be selectively increased in the small intestinal mucosa of patients in the acute phase of KD compared with controls (p < 0.01). In our previous study, five kinds of streptococci and two kinds of staphylococci, not detected in control patients, were isolated from the lumen of the jejunum of KD patients. These data suggest that the increased occurrence of Vβ2+ T cells in the jejunal mucosa of KD patients may be caused by exotoxins acting as superantigens produced by bacteria colonizing the small intestinal mucosa of these patients.Keywords
This publication has 8 references indexed in Scilit:
- Evidence for a superantigen mediated process in Kawasaki disease.Archives of Disease in Childhood, 1995
- TCR V beta family repertoire and T cell activation markers in Kawasaki disease.The Journal of Immunology, 1994
- Fate of iron stores in thalassaemia after bone-marrow transplantationThe Lancet, 1993
- Immunohistochemical Studies on Small Intestinal Mucosa in Kawasaki DiseasePediatric Research, 1993
- Characterization of T cell repertoire changes in acute Kawasaki disease.The Journal of Experimental Medicine, 1993
- Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.Proceedings of the National Academy of Sciences, 1992
- Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.Journal of Clinical Investigation, 1987
- A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in JapanPediatrics, 1974